Skip to main content
Inmazeb 483.3 mg/14.5mL, 483.3 mg/14.5mL, 483.3 mg/14.5mL injection, solution by Regeneron Pharmaceuticals, Inc.
Inmazeb, 483.3 mg/14.5mL, 483.3 mg/14.5mL, 483.3 mg/14.5mL, injection, solution Available on prescription only. Listed by Regeneron Pharmaceuticals, Inc..
Prescription only

Inmazeb

atoltivimab, maftivimab, and odesivimab-ebgn

Listed by Regeneron Pharmaceuticals, Inc.

Strength
483.3 mg/14.5mL, 483.3 mg/14.5mL, 483.3 mg/14…
Form
Injection, Solution
Route
Intravenous

What it contains

  • Atoltivimab 483.3 mg/14.5mL
  • Maftivimab 483.3 mg/14.5mL
  • Odesivimab 483.3 mg/14.5mL

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Injection, Solution
Route Intravenous
Approval route BLA — biologic licence
NDC code 61755-019
FDA application BLA761169
RxNorm concept 2461536
Package sizes listed 1
Marketed since July 2021

Other products containing Atoltivimab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Inmazeb

atoltivimab, maftivimab, and odesivimab-ebgn

Strength
241.7 mg/14.5mL, 241.7 mg/14.5mL, 241.7…
Form
Injection, Solution
Rx only

Regeneron Pharmaceuticals, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.